XML 66 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
(11) Common Stock and Common Stock Equivalents
12 Months Ended
Jun. 30, 2015
Notes  
(11) Common Stock and Common Stock Equivalents

(11)  Common Stock and Common Stock Equivalents

For the year ended June 30, 2015, the Company granted no restricted common stock to directors or officers in connection with compensation arrangements. For the year ended June 30, 2014, the Company granted 1,485 shares of restricted common stock to directors in connection with compensation arrangements.

On June 30, 2015, the Company issued 122,000 shares of restricted common stock to the exclusive placement agent and the financial advisor in conjunction with the $4 million capital raise.

The Company maintained a 2005 equity incentive plan for the benefit of employees, on June 29, 2015 the shareholders approved a new 2015 equity incentive plan setting aside 500,000 shares. The 2015 plan was filed with the SEC on September 3, 2015. Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plan.  Awards granted under the plan may be performance-based. As of June 30, 2015, 500,000 shares of common stock were authorized and reserved for issuance, but were not granted under the terms of the 2015 equity incentive plan. No further grants will be made under the 2005 plan.

The Company granted no options under its 2005 or 2015 equity incentive plan during fiscal year 2015. The Company granted 3,598 options to acquire common stock during fiscal year 2014. The options are granted at not less than 100% of the market price of the stock at the date of grant. Option terms are determined by the board, and exercise dates may range from 6 months to 10 years from the date of grant.

The fair value of each option grant was estimated on the date of grant using the Black Scholes option pricing model with the following assumptions:

 

 

 

 

 

 

 

 

 

2014

 

Expected dividend yield

 

0%

 

Expected stock price volatility

 

69%

 

Risk-free interest rate

 

2.53%

 

Expected life of options

 

 10 years

 

 

The weighted average fair value of options granted during fiscal year 2014 was $1.89.

The following table summarizes the Company’s stock option activity during the reported fiscal years:

 

 

 

 

 

 

 

 

 

2015

 

2014

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

average

 

 

Weighted

 

 

 

 

 

 

 

 

Number

 

average

remaining

Number

 

average

 

 

 

 

 

 

 

 

of

 

exercise

contractual

of

 

exercise

 

 

 

 

 

 

 

 

shares

 

price

term

shares

 

price

Options outstanding at

 

 

 

 

 

 

 

 

 

beginning of the year

 

155,604

$

6.45 

3.56 years

163,868

$

6.51 

Options granted

 

       -

 

    -

 

3,598

 

2.42

Options exercised

 

       -

 

    -

 

-

 

       -

Options canceled or expired

 

(64,452)

 

8.41

 

(11,862)

 

6.01

Options outstanding at end

 

 

 

 

 

 

 

 

 

of the year

 

91,152

 

5.07

2.80 years

155,604

 

6.45

Options exercisable at end

 

 

 

 

 

 

 

 

 

of the year

 

90,520

 

5.48

 

137,804

 

7.09

Range of exercise prices at

 

 

 

 

 

 

 

 

 

end of the year

 

 

$

1.75 – 7.10

 

 

$

1.75 – 8.60

 

The Company recognized $66,372 and $70,871 in stock-based compensation for the years ended June 30, 2015 and 2014, respectively, which is included in selling, general, and administrative expenses in the consolidated statements of operations. The stock-based compensation includes amounts for both restricted stock and stock options under ASC 718.

As of June 30, 2015 there was $327,483 of unrecognized stock-based compensation cost that is expected to be expensed over periods of 4 to 9 years.

No options were exercised during the fiscal years 2015 and 2014. The aggregate intrinsic value of the outstanding options as of June 30, 2015 and 2014 was $3,289 and $8,732, respectively.